Further studies to determine the efficacy of the ACE2/TMPRSS2‐EVs in experimental models of SARS‐CoV‐2 virus need to be conducted to validate their therapeutic use for COVID‐19, but also the lack of side‐effects. The gene discussed is ACE2; the disease is COVID-19.